Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines

Sabine Rutti, Rodolphe Dusaulcy, Jakob S. Hansen, Cédric Howald, Emmanouil T. Dermitzakis, Bente K. Pedersen, Michel Pinget, Peter Plomgaard, Karim Bouzakri

14 Citations (Scopus)
29 Downloads (Pure)

Abstract

Tissue cross-talk is emerging as a determinant way to coordinate the different organs implicated in glucose homeostasis. Among the inter-organ communication factors, muscle-secreted myokines can modulate the function and survival of pancreatic beta-cells. Using primary human myotubes from soleus, vastus lateralis and triceps brachii muscles, we report here that the impact of myokines on beta-cells depends on fiber types and their metabolic status. We show that Type I and type II primary myotubes present specific mRNA and myokine signatures as well as a different sensitivity to TNF-alpha induced insulin resistance. Finally, we show that angiogenin and osteoprotegerin are triceps specific myokines with beta-cell protective actions against proinflammatory cytokines. These results suggest that type I and type II muscles could impact insulin secretion and beta-cell mass differentially in type 2 diabetes through specific myokines secretion.

Original languageEnglish
Article number10072
JournalScientific Reports
Volume8
Number of pages10
ISSN2045-2322
DOIs
Publication statusPublished - 1 Dec 2018

Fingerprint

Dive into the research topics of 'Angiogenin and Osteoprotegerin are type II muscle specific myokines protecting pancreatic beta-cells against proinflammatory cytokines'. Together they form a unique fingerprint.

Cite this